Penobscot Investment Management Company, Inc. Novo Nordisk A S Transaction History

Penobscot Investment Management Company, Inc.

$1.15 Billion
Q2 2025

A detailed history of Penobscot Investment Management Company, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Penobscot Investment Management Company, Inc. holds 26,863 shares of NVO stock, worth $1.34 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

26,863

Previous 33,322 19.38%

Holding current value

$1.34 Million

Previous $2.31 Million 19.84%

% of portfolio

0.16%

Previous 0.22%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 21, 2025	SELL	$58.08 - $81.05 $375,138 - $523,501	-6,459 Reduced 19.38%	26,863 $1.85 Million
Q1 2025 Apr 23, 2025	SELL	$69.3 - $90.95 $155,717 - $204,364	-2,247 Reduced 6.32%	33,322 $2.31 Million
Q4 2024 Feb 11, 2025	SELL	$85.0 - $120.04 $497,250 - $702,234	-5,850 Reduced 14.12%	35,569 $3.06 Million
Q3 2024 Nov 12, 2024	BUY	$119.07 - $145.42 $73,823 - $90,160	620 Added 1.52%	41,419 $4.93 Million
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $250,328 - $299,696	2,040 Added 5.26%	40,799 $5.82 Million
Q1 2024 May 13, 2024	BUY	$102.11 - $135.92 $672,394 - $895,033	6,585 Added 20.47%	38,759 $4.98 Million
Q4 2023 Feb 05, 2024	BUY	$87.78 - $105.45 $374,732 - $450,166	4,269 Added 15.3%	32,174 $3.33 Million
Q3 2023 Nov 08, 2023	BUY	$90.94 - $199.54 $1.45 Million - $3.18 Million	15,925 Added 132.93%	27,905 $2.54 Million
Q2 2023 Aug 10, 2023	BUY	$155.98 - $172.65 $45,234 - $50,068	290 Added 2.48%	11,980 $1.94 Million
Q1 2022 May 11, 2022	SELL	$93.1 - $112.54 $51,205 - $61,897	-550 Reduced 4.49%	11,690 $1.3 Million
Q3 2021 Nov 08, 2021	SELL	$84.42 - $106.62 $84,420 - $106,620	-1,000 Reduced 7.55%	12,240 $1.18 Million
Q2 2020 Aug 04, 2020	SELL	$58.54 - $67.94 $702 - $815	-12 Reduced 0.09%	13,240 $867,000
Q1 2020 May 07, 2020	SELL	$49.46 - $64.78 $150,853 - $197,579	-3,050 Reduced 18.71%	13,252 $798,000
Q4 2019 Feb 04, 2020	SELL	$49.86 - $58.26 $9,972 - $11,652	-200 Reduced 1.21%	16,302 $944,000
Q3 2019 Nov 05, 2019	SELL	$47.54 - $53.43 $220,823 - $248,182	-4,645 Reduced 21.97%	16,502 $853,000
Q2 2019 Aug 02, 2019	SELL	$46.79 - $52.47 $101,908 - $114,279	-2,178 Reduced 9.34%	21,147 $1.08 Million
Q4 2018 Feb 12, 2019	SELL	$41.54 - $47.25 $150,374 - $171,045	-3,620 Reduced 13.43%	23,325 $1.08 Million
Q3 2018 Nov 01, 2018	SELL	$46.76 - $51.24 $21,977 - $24,082	-470 Reduced 1.71%	26,945 $1.27 Million
Q2 2018 Aug 07, 2018	SELL	$44.29 - $50.42 $199,526 - $227,142	-4,505 Reduced 14.11%	27,415 $1.26 Million
Q1 2018 May 07, 2018	SELL	$48.49 - $58.14 $11,152 - $13,372	-230 Reduced 0.72%	31,920 $1.57 Million
Q3 2017 Nov 02, 2017	BUY	$41.15 - $49.22 $1.32 Million - $1.58 Million	32,150	32,150 $1.55 Million

Others Institutions Holding NVO

# of Institutions

1,744

Shares Held

337M

Call Options Held

10.7M

Put Options Held

16M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $112B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Penobscot Investment Management Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Penobscot Investment Management Company, Inc. with notifications on news.

Account

Penobscot Investment Management Company, Inc. Novo Nordisk A S Transaction History